The Microcirculation, Dialysis Modality and Sequestered Salt

NANot yet recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
End-stage Renal Disease
Interventions
DEVICE

Hemodialysis (DNa = PNa)

High-flux hemodialysis with an expected zero diffusive sodium balance (DNa = PNa)

DEVICE

Hemodialysis (DNa<PNa)

High-flux hemodialysis with expected diffusive sodium efflux (DNa\<PNa, difference: 3 mmol/L)

DEVICE

Hemodialysis after isolated ultrafiltration (DNa=PNa)

High-flux hemodialysis after isolated ultrafiltration with an expected zero diffusive sodium balance (DNa=PNa)

DEVICE

High volume hemodiafiltration (DNa=PNa)

High volume hemodiafiltration with an expected zero diffusive sodium balance (DNa=PNa) Convection volume: ≥23L/session

DEVICE

High volume hemodiafiltration (DNa<PNa)

High volume hemodiafiltration with expected diffusive sodium efflux (DNa\<PNa, difference: 3 mmol/L) Convection volume: ≥23L/session

All Listed Sponsors
collaborator

Dutch Kidney Foundation

OTHER

collaborator

Niercentrum aan de Amstel

UNKNOWN

collaborator

B.Braun Avitum AG

INDUSTRY

lead

Amsterdam UMC, location VUmc

OTHER

NCT06327750 - The Microcirculation, Dialysis Modality and Sequestered Salt | Biotech Hunter | Biotech Hunter